Nabumetone Tablet
Product Images NDC 69367-242

5 FDA label images from Westminster Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 69367-242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nabumetone 01)

Chemical Structure (Nabumetone 01)
Chemical structure of Nabumetone, showing its molecular arrangement including aromatic rings and functional groups.*
FDA Label Image

Chemical Structure (Nabumetone 02)

Chemical Structure (Nabumetone 02)
Chemical structure of Nabumetone, showing a naphthalene ring system with a methoxy group and a carboxylic acid functional group attached by an ethyl chain.*
FDA Label Image

Figure (Nabumetone 03)

Figure (Nabumetone 03)
A pharmacokinetic graph showing Nabumetone active metabolite (6MNA) plasma concentrations over 70 hours at steady state after once-daily dosing of 1000 mg (n=31) and 2000 mg (n=12). It includes mean concentrations with ±2 standard deviation bands for each dose, with concentration (mcg/mL) on the y-axis and time (hours) on the x-axis.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
Nabumetone Tablets USP 500 mg oral tablets label, containing 500 tablets. The label states the active ingredient as Nabumetone USP 500 mg per tablet. Manufactured by ScieGen Pharmaceuticals, Inc. for Westminster Pharmaceuticals, LLC. Storage instructions specify temperature control. The label includes a barcode and NDC 69367-241-05.*
FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

Principal Display Panel (750 mg Tablet Bottle Label)
Nabumetone Tablets, USP 750 mg oral tablets packaging label. The label specifies the strength as 750 mg and the package count of 500 tablets. It is manufactured for Westminster Pharmaceuticals, LLC. Storage instructions and a caution to keep medication out of children’s reach are noted. The label includes the NDC 69367-242-05 barcode and emphasizes prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.